Literature DB >> 52406

The integration of chemotherapy into a combined modality approached to cancer therapy. V. Squamous cell cancer of the head and neck.

M A Goldsmith, S K Carter.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 52406     DOI: 10.1016/s0305-7372(75)80007-7

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN: 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  7 in total

1.  Randomized comparison of cis-diamminedichloroplatinum versus cis-diamminedichloroplatinum, methotrexate, and bleomycin in recurrent squamous cell carcinoma of the head and neck.

Authors:  S Davis; W Kessler
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

2.  Update in cancer chemotherapy: head and neck cancer, Part 1.

Authors:  J C Wright
Journal:  J Natl Med Assoc       Date:  1986-10       Impact factor: 1.798

3.  The clinical evaluation of analogues II. Bleomycins.

Authors:  S K Carter
Journal:  Cancer Chemother Pharmacol       Date:  1978       Impact factor: 3.333

4.  Selective intra-arterial cytotostatic injections in malignant head and neck tumors.

Authors:  J Brismar; A Björklund; A Elner; C M Eneroth
Journal:  Neuroradiology       Date:  1978       Impact factor: 2.804

5.  Combined chemotherapy of head and neck squamous cell carcinomas with methotrexate, bleomycin, and hydroxyurea.

Authors:  R Medenica; P Alberto; W Lehmann
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

6.  Methotrexate treatment of squamous-cell head and neck cancers: dose-response evaluation.

Authors:  R L Woods; R M Fox; M H Tattersall
Journal:  Br Med J (Clin Res Ed)       Date:  1981-02-21

7.  Intravenous chemotherapy with syndronization in advanced cancer of oral cavity and oropharynx.

Authors:  M Auersperg; E Soba; O Vraspir-Porenta
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1977-11-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.